Why the study?
Strong evidence supporting the clinical significance of CT-measured EAT attenuation, reflecting localized inflammation, in predicting AF ablation efficacy remains limited.
Do epicardial adipose tissue parameters assessed by CT predict arrhythmia recurrence in patients undergoing first-time ablation for paroxysmal AF?
Population
Fifty-two patients with paroxysmal AF undergoing first-time, single-shot pulmonary vein isolation
Comparison
CT-assessed EAT volume and mean attenuation parameters compared by arrhythmia recurrence status
Design
Prospective cohort study
Follow-up
Median 14 months (Q1-Q3: 10-21 months)
Key result
Increased epicardial adipose tissue attenuation on CT correlates with reduced success rate (57.69%) of atrial fibrillation ablation in paroxysmal AF patients.
Authors
Loading...
EAT attenuation on CT may serve as a prognostic marker for ablation outcomes in paroxysmal AF; leaves open its role in patient selection pending validation.
Do epicardial adipose tissue parameters assessed by CT predict arrhythmia recurrence in patients undergoing first-time ablation for paroxysmal AF?
Increased inflammatory activity of epicardial adipose tissue, measured via CT attenuation, may serve as a prognostic marker for reduced efficacy of AF ablation.
Momot et al. (2025) studied this question. Increased epicardial adipose tissue attenuation on CT correlates with reduced success rate (57.69%) of atrial fibrillation ablation in paroxysmal AF patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: